» Articles » PMID: 26589884

Interaction of Natural Killer Cells with Neutrophils Exerts a Significant Antitumor Immunity in Hematopoietic Stem Cell Transplantation Recipients

Overview
Journal Cancer Med
Specialty Oncology
Date 2015 Nov 22
PMID 26589884
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Autologous hematopoietic stem cell transplantation (HSCT) can induce a strong antitumor immunity by homeostatic proliferation (HP) of T cells and suppression of regulatory T cells following preconditioning-induced lymphopenia. However, the role of innate immunity including natural killer (NK) cells is still not understood. Here, first, we examined whether NK cells exert an antitumor effect after syngeneic HSCT in a murine colon cancer model. Flow cytometry showed that NK cells as well as T cells rapidly proliferated after HSCT, and the frequency of mature NK cells was increased in tumor during HP. Furthermore, NK cells undergoing HP were highly activated, which contributed to substantial tumor suppression. Then, we found that a large number of neutrophils accumulated in tumor early after syngeneic HSCT. It was recently reported that neutrophil-derived mediators modulate NK cell effector functions, and so we examined whether the neutrophils infiltrated in tumor are associated with NK cell-mediated antitumor effect. The depletion of neutrophils significantly impaired an activation of NK cells in tumor and increased the fraction of proliferative NK cells accompanied by a decrease in NK cell survival. The results suggested that neutrophils in tumor prevent NK cells from activation-induced cell death during HP, thus leading to a significant antitumor effect by NK cells. This study revealed a novel aspect of antitumor immunity induced by HSCT and may contribute to the development of an effective therapeutic strategy for cancer using HSCT.

Citing Articles

The 'Danse Macabre'-Neutrophils the Interactive Partner Affecting Oral Cancer Outcomes.

Hadjigol S, Shah B, OBrien-Simpson N Front Immunol. 2022; 13:894021.

PMID: 35784290 PMC: 9243430. DOI: 10.3389/fimmu.2022.894021.


Neutrophils in cancer: heterogeneous and multifaceted.

Hedrick C, Malanchi I Nat Rev Immunol. 2021; 22(3):173-187.

PMID: 34230649 DOI: 10.1038/s41577-021-00571-6.


Tumor-associated neutrophils suppress antitumor immunity of NK cells through the PD-L1/PD-1 axis.

Sun R, Xiong Y, Liu H, Gao C, Su L, Weng J Transl Oncol. 2020; 13(10):100825.

PMID: 32698059 PMC: 7372151. DOI: 10.1016/j.tranon.2020.100825.


Neutrophil diversity and plasticity in tumour progression and therapy.

Jaillon S, Ponzetta A, Di Mitri D, Santoni A, Bonecchi R, Mantovani A Nat Rev Cancer. 2020; 20(9):485-503.

PMID: 32694624 DOI: 10.1038/s41568-020-0281-y.


Loss of CXCR4 in Myeloid Cells Enhances Antitumor Immunity and Reduces Melanoma Growth through NK Cell and FASL Mechanisms.

Yang J, Kumar A, Vilgelm A, Chen S, Ayers G, Novitskiy S Cancer Immunol Res. 2018; 6(10):1186-1198.

PMID: 30108045 PMC: 6170679. DOI: 10.1158/2326-6066.CIR-18-0045.


References
1.
Borrello I, Sotomayor E, Rattis F, Cooke S, Gu L, Levitsky H . Sustaining the graft-versus-tumor effect through posttransplant immunization with granulocyte-macrophage colony-stimulating factor (GM-CSF)-producing tumor vaccines. Blood. 2000; 95(10):3011-9. View

2.
Sporri R, Joller N, Hilbi H, Oxenius A . A novel role for neutrophils as critical activators of NK cells. J Immunol. 2008; 181(10):7121-30. DOI: 10.4049/jimmunol.181.10.7121. View

3.
Restifo N, Dudley M, Rosenberg S . Adoptive immunotherapy for cancer: harnessing the T cell response. Nat Rev Immunol. 2012; 12(4):269-81. PMC: 6292222. DOI: 10.1038/nri3191. View

4.
Vosshenrich C, Samson-Villeger S, Di Santo J . Distinguishing features of developing natural killer cells. Curr Opin Immunol. 2005; 17(2):151-8. DOI: 10.1016/j.coi.2005.01.005. View

5.
Dummer W, Niethammer A, Baccala R, Lawson B, Wagner N, Reisfeld R . T cell homeostatic proliferation elicits effective antitumor autoimmunity. J Clin Invest. 2002; 110(2):185-92. PMC: 151053. DOI: 10.1172/JCI15175. View